查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942795

2026年全球電子藥物傳輸系統市場報告

Electronic Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，電子藥物輸送系統市場規模顯著成長，預計將從2025年的119.3億美元成長到2026年的131.1億美元，複合年成長率達9.9%。過去幾年的成長可歸因於多種因素，例如慢性病盛行率上升、注射和吸入療法的推廣、輸液療法的使用增加、居家醫療的普及以及電子藥物輸送平台的廣泛應用。

預計未來幾年，電子藥物輸送系統市場將快速成長，到2030年市場規模將達到194.4億美元，複合年成長率（CAGR）為10.4%。預測期內的成長要素包括：對個人化藥物輸送的需求不斷成長、數位健康生態系統的日益普及、遠端患者監護的擴展、對基於依從性的治療結果的日益關注，以及基於人工智慧的給藥演算法的日益整合。預測期內的主要趨勢包括：智慧型藥物輸送設備的日益普及、互聯穿戴式輸送系統的日益整合、精準給藥控制技術的日益廣泛應用、以患者為中心的自我給藥設備的擴展，以及對治療依從性監測的日益重視。

電子藥物輸送系統市場預計將因慢性病盛行率的不斷上升而成長。持續一年以上且需要長期治療的慢性病患者可受益於電子藥物傳輸系統，有助於調整和監測藥物劑量。例如，根據美國國家醫學圖書館2023年1月發布的報告，到2050年，美國50歲及以上至少有一種慢性病的人口預計將達到1.4266億。慢性病盛行率的上升趨勢預計將進一步增加對電子藥物傳輸系統的需求。

電子藥物管理系統市場的主要企業正致力於創新解決方案，例如可重複使用的電子注射平台，以提高給藥準確性、患者依從性和永續性。可重複使用的電子注射平台是電池供電的多用途智慧設備，能夠實現精準給藥，同時追蹤用藥情況並支持患者依從性。例如，2025年1月，美國醫療設備製造商Portal Instruments Inc.發布了PRIME Nexus，這是一款可重複使用的電子注射平台，旨在提高注射給藥的準確性、通用性和永續性。本系統相容於多種規格的藥物容器，包括1毫升和2.25毫升預填充式注射器以及3毫升藥筒，並可處理黏度高達600 cP的高黏度製劑。它具有可程式設計注射控制功能，並可選配連接功能，用於監測用藥依從性並與醫療保健提供者共用數據。其可重複使用的設計減少了醫療廢棄物，降低了整體注射成本，從而支持永續性。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球電子藥物輸送系統市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
  • 主要趨勢
    • 智慧型藥物傳輸裝置的應用日益普及
    • 互聯穿戴式藥物輸送系統正變得越來越一體化
    • 擴大精準劑量控制技術的應用
    • 擴展以病人為中心的自我管理設備
    • 更重視治療依從性監測。

第5章 終端用戶產業市場分析

  • 醫院
  • 居家醫療保健服務提供者
  • 專科診所
  • 門診治療中心
  • 藥局

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球電子藥物輸送系統市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球電子藥物傳輸系統市場規模、比較及成長率分析
  • 全球電子藥物傳輸系統市場表現：規模與成長，2020-2025年
  • 全球電子藥物傳輸系統市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 電子輸液幫浦、電子注射筆、電子自動注射器、電子吸入器、電子膠囊
  • 按組件
  • 感測器、無線通訊設備和天線、微型泵浦和流量調節器、藥物儲庫、微控制器及其他組件
  • 依系統類型
  • 電池供電系統，可充電系統
  • 透過分銷管道
  • 醫院藥房、零售藥房
  • 透過使用
  • 糖尿病、心血管疾病、呼吸系統疾病、多發性硬化症等用途
  • 按類型細分：電子輸液泵
  • 容積式輸液幫浦、注射式輸液幫浦、攜帶式輸液幫浦
  • 按類型細分：電子注射筆
  • 胰島素筆、生長激素筆和其他注射式藥物筆
  • 按類型細分：電子自動注射器
  • 預填充自動注射器，彈簧式自動注射器
  • 按類型細分：電子吸入器
  • 定量吸入器（MDI）、乾粉吸入器（DPI）、緩霧吸入器
  • 按類型細分：電子膠囊
  • 智慧膠囊，帶感測器的數位膠囊

第10章 區域與國家分析

  • 全球電子藥物輸送系統市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球電子藥物輸送系統市場：依國家分類、績效及預測（2020-2025年、2025-2030年預測、2035年預測）

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 電子藥物輸送系統市場：競爭格局及市場佔有率（2024 年）
  • 電子藥物輸送系統市場：公司估值矩陣
  • 電子藥物輸送系統市場：公司概況
    • Medtronic plc
    • Novo Nordisk A/S
    • Insulet Corporation
    • Tandem Diabetes Care Inc.
    • United Therapeutics Corporation

第37章：其他領先和創新企業

  • Sanofi SA, Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z oo, HCmed Innovations Co. Ltd, Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年電子藥物輸送系統市場：提供新機會的國家
  • 電子藥物輸送系統市場展望（2030）：新興細分市場機會
  • 電子藥物輸送系統市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MEDDS01_G26Q1

Electronic drug delivery systems encompass devices or formulations designed to facilitate the targeted delivery of a medical substance to a specific region while avoiding non-target cells and tissues. These systems ensure the controlled administration of drugs, allowing for easy monitoring of doses.

The primary categories of electronic drug delivery systems include electronic infusion pumps, electronic injection pens, electronic auto-injectors, electronic inhalers, electronic capsules, and other variants. Electronic infusion pumps are medical devices that regulate the controlled delivery of fluids into a patient's body. Deployed in healthcare settings such as hospitals and nursing homes, these pumps are instrumental in delivering fluids such as nutrients and medications. Essential components of electronic drug delivery systems comprise sensors, wireless communicators, antennas, micro-pumps, flow regulators, drug reservoirs, microcontrollers, and other elements, available in both battery-powered and rechargeable systems. These electronic drug delivery systems are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, catering to the treatment of various conditions such as diabetes, cardiovascular disease, respiratory disorders, multiple sclerosis, and other ailments.

Tariffs are impacting the electronic drug delivery systems market by increasing costs of imported sensors, microcontrollers, batteries, wireless modules, and precision pumps used in smart delivery devices. Pharmaceutical and medical device manufacturers in North America and Europe are most affected due to reliance on imported electronic components, while Asia-Pacific faces cost pressure on device assembly. These tariffs are increasing production costs and device pricing. However, they are also encouraging domestic component sourcing, local assembly, and innovation in cost-efficient electronic drug delivery solutions.

The electronic drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides electronic drug delivery systems market statistics, including electronic drug delivery systems industry global market size, regional shares, competitors with a electronic drug delivery systems market share, detailed electronic drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the electronic drug delivery systems industry. This electronic drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $11.93 billion in 2025 to $13.11 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, expansion of injectable and inhalable therapies, increasing use of infusion-based treatments, growth in home healthcare adoption, availability of electronic drug delivery platforms.

The electronic drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $19.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for personalized drug delivery, rising adoption of digital health ecosystems, expansion of remote patient monitoring, growing focus on adherence-driven outcomes, increasing integration of ai-based dosing algorithms. Major trends in the forecast period include increasing adoption of smart drug delivery devices, rising integration of connected and wearable delivery systems, growing use of precision dose control technologies, expansion of patient-centric self-administration devices, enhanced focus on therapy adherence monitoring.

The anticipated growth of the electronic drug delivery systems market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for more than a year and necessitating ongoing medical treatment, can benefit from electronic drug delivery systems that aid in regulating and monitoring drug doses. For example, in January 2023, the National Library of Medicine reported that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to reach 142.66 million by 2050. This upward trend in chronic diseases is poised to fuel the demand for electronic drug delivery systems.

Major companies in the electronic drug delivery systems market are increasingly focusing on innovative solutions, such as reusable electronic injector platforms, to improve dosing accuracy, patient adherence, and sustainability. Reusable electronic injector platforms are battery-powered, smart devices designed for multiple uses, delivering precise medication doses while tracking usage and supporting adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, launched the PRIME Nexus, a reusable electronic injector platform engineered to enhance the administration of injectable medications with improved precision, versatility, and sustainability. The system accommodates multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can handle high-viscosity formulations up to 600 cP. It provides programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable design supports sustainability by reducing medical waste and lowering overall injection costs.

In November 2025, Biogen Inc., a US-based biotechnology company, acquired Alcyone Therapeutics for an undisclosed amount. Through this acquisition, Biogen aims to strengthen its central nervous system (CNS) drug delivery capabilities and expand its pipeline of targeted therapies. Alcyone Therapeutics Inc., a US-based healthcare technology company, specializes in developing advanced drug delivery platforms designed to enhance precision and efficacy in the treatment of neurological disorders.

Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.

North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electronic drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The electronic drug delivery systems market consists of sales of nasal sprays, eyedroppers, and intrauterine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses electronic drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for electronic drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Electronic Infusion Pumps; Electronic Injection Pens; Electronic Auto-Injectors; Electronic Inhalers; Electronic Capsules
  • 2) By Component: Sensors; Wireless Communicator And Antennas; Micro Pumps And Flow Regulators; Drug Reservoir; Microcontroller; Other Components
  • 3) By System Type: Battery-Powered Systems; Rechargeable Systems
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies
  • 5) By Application: Diabetes; Cardiovascular Disease; Respiratory Disorders; Multiple Sclerosis; Other Applications
  • Subsegments:
  • 1) By Electronic Infusion Pumps: Volumetric Infusion Pumps; Syringe Infusion Pumps; Ambulatory Infusion Pumps
  • 2) By Electronic Injection Pens: Insulin Pens; Growth Hormone Pens; Other Injectable Medication Pens
  • 3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors; Spring-Loaded Auto-Injectors
  • 4) By Electronic Inhalers: Metered Dose Inhalers (MDI); Dry Powder Inhalers (DPI); Soft Mist Inhalers
  • 5) By Electronic Capsules: Smart Capsules; Digital Capsules With Sensors
  • Companies Mentioned: Medtronic plc; Novo Nordisk A/S; Insulet Corporation; Tandem Diabetes Care Inc.; United Therapeutics Corporation; Sanofi S.A.; Abbott Laboratories; Roche Holding AG; Johnson & Johnson; Bayer AG; Antares Pharma Inc.; CeQur Corporation; BIOCORP; Adherium Limited; Amiko Digital Health Limited; FindAir Sp. z o.o.; HCmed Innovations Co. Ltd.; Insulet International Limited; Ypsomed Holding AG; Enable Injections Inc.; Eitan Medical Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Electronic Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Electronic Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Electronic Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Electronic Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Smart Drug Delivery Devices
    • 4.2.2 Rising Integration Of Connected And Wearable Delivery Systems
    • 4.2.3 Growing Use Of Precision Dose Control Technologies
    • 4.2.4 Expansion Of Patient-Centric Self-Administration Devices
    • 4.2.5 Enhanced Focus On Therapy Adherence Monitoring

5. Electronic Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Home Healthcare Providers
  • 5.3 Specialty Clinics
  • 5.4 Ambulatory Care Centers
  • 5.5 Pharmacies

6. Electronic Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Electronic Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Electronic Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Electronic Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Electronic Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Electronic Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Electronic Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Electronic Drug Delivery Systems Market Segmentation

  • 9.1. Global Electronic Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
  • 9.2. Global Electronic Drug Delivery Systems Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
  • 9.3. Global Electronic Drug Delivery Systems Market, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Battery-Powered Systems, Rechargeable Systems
  • 9.4. Global Electronic Drug Delivery Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies
  • 9.5. Global Electronic Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
  • 9.6. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Infusion Pumps, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
  • 9.7. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Injection Pens, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
  • 9.8. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Auto-Injectors, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
  • 9.9. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
  • 9.10. Global Electronic Drug Delivery Systems Market, Sub-Segmentation Of Electronic Capsules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Smart Capsules, Digital Capsules With Sensors

10. Electronic Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Electronic Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Electronic Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Electronic Drug Delivery Systems Market

  • 11.1. Asia-Pacific Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Electronic Drug Delivery Systems Market

  • 12.1. China Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Electronic Drug Delivery Systems Market

  • 13.1. India Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Electronic Drug Delivery Systems Market

  • 14.1. Japan Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Electronic Drug Delivery Systems Market

  • 15.1. Australia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Electronic Drug Delivery Systems Market

  • 16.1. Indonesia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Electronic Drug Delivery Systems Market

  • 17.1. South Korea Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Electronic Drug Delivery Systems Market

  • 18.1. Taiwan Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Electronic Drug Delivery Systems Market

  • 19.1. South East Asia Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Electronic Drug Delivery Systems Market

  • 20.1. Western Europe Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Electronic Drug Delivery Systems Market

  • 21.1. UK Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Electronic Drug Delivery Systems Market

  • 22.1. Germany Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Electronic Drug Delivery Systems Market

  • 23.1. France Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Electronic Drug Delivery Systems Market

  • 24.1. Italy Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Electronic Drug Delivery Systems Market

  • 25.1. Spain Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Electronic Drug Delivery Systems Market

  • 26.1. Eastern Europe Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Electronic Drug Delivery Systems Market

  • 27.1. Russia Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Electronic Drug Delivery Systems Market

  • 28.1. North America Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Electronic Drug Delivery Systems Market

  • 29.1. USA Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Electronic Drug Delivery Systems Market

  • 30.1. Canada Electronic Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Electronic Drug Delivery Systems Market

  • 31.1. South America Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Electronic Drug Delivery Systems Market

  • 32.1. Brazil Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Electronic Drug Delivery Systems Market

  • 33.1. Middle East Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Electronic Drug Delivery Systems Market

  • 34.1. Africa Electronic Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Electronic Drug Delivery Systems Market, Segmentation By Type, Segmentation By Component, Segmentation By System Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Electronic Drug Delivery Systems Market Regulatory and Investment Landscape

36. Electronic Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Electronic Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Electronic Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Electronic Drug Delivery Systems Market Company Profiles
    • 36.3.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Insulet Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Tandem Diabetes Care Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. United Therapeutics Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Electronic Drug Delivery Systems Market Other Major And Innovative Companies

  • Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o, HCmed Innovations Co. Ltd, Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc

38. Global Electronic Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Electronic Drug Delivery Systems Market

40. Electronic Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Electronic Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Electronic Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Electronic Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer